A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population
Authors
Keywords
BRCA1, BRCA2, Ovarian cancer, French Canadian, Mutation frequency, Genetic testing, Founder
Journal
Journal of Ovarian Research
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-02-10
DOI
10.1186/s13048-015-0124-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Screening for BRCA1 and BRCA2 mutations among French-Canadian breast cancer cases attending an outpatient clinic in Montreal
- (2013) P Ghadirian et al. CLINICAL GENETICS
- Preventing ovarian cancer through genetic testing: a population-based study
- (2013) A. Finch et al. CLINICAL GENETICS
- A Classification Model for BRCA2 DNA Binding Domain Missense Variants Based on Homology-Directed Repair Activity
- (2012) L. Guidugli et al. CANCER RESEARCH
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2012) Kathryn Alsop et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Ovarian Cancer Survival Associated With Mutation in BRCA1 or BRCA2
- (2012) John R. McLaughlin et al. JNCI-Journal of the National Cancer Institute
- Germline BRCA1 and BRCA2 Mutations in Ovarian Cancer
- (2012) Kasmintan A. Schrader et al. OBSTETRICS AND GYNECOLOGY
- Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
- (2011) P. M. L. H. Vencken et al. ANNALS OF ONCOLOGY
- The BRCA2 c.9004G>A (E2003K) variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descent
- (2011) Stephanie Cote et al. BREAST CANCER RESEARCH AND TREATMENT
- Improved survival forBRCA2-associated serous ovarian cancer compared with bothBRCA-negative andBRCA1-associated serous ovarian cancer
- (2011) David M. Hyman et al. CANCER
- Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer
- (2011) Shiyu Zhang et al. GYNECOLOGIC ONCOLOGY
- Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer
- (2011) Jonathan A. Ledermann et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
- (2011) Da Yang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
- (2011) T. Walsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer
- (2010) Luca Cavallone et al. Familial Cancer
- Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube
- (2010) Danielle Vicus et al. GYNECOLOGIC ONCOLOGY
- The contribution of founder mutations to early-onset breast cancer in French-Canadian women
- (2009) P Ghadirian et al. CLINICAL GENETICS
- BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications
- (2009) Allison W Kurian CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
- (2009) T. R. Rebbeck et al. JNCI-Journal of the National Cancer Institute
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Uptake of clinical genetic testing for ovarian cancer in Ontario: A population-based study
- (2008) Kelly A. Metcalfe et al. GYNECOLOGIC ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now